$18.48
-0.09-0.48%
Last update: Oct 30, 4:53 PM
Nuvectis Pharma Inc (NVCT) Stock Price, Quote, News & History
NVCTNASDAQ
Analysts downgraded UiPath, Cal-Maine with several price-target cuts.
You can purchase shares of Nuvectis Pharma (NASDAQ:NVCT) through any online brokerage.
Other companies in Nuvectis Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Nuvectis Pharma has a consensus price target of $27.00.
The stock price for Nuvectis Pharma (NASDAQ: NVCT) is $19.5 last updated October 30, 2026 at 4:53 PM EDT.
There are no upcoming dividends for Nuvectis Pharma.
Nuvectis Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Nuvectis Pharma.
Nuvectis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development...
